Thinking differently the patient medication compliance: from an injunctive posture to a working alliance between the patient and the healthcare provider: concepts and determinants

Annales pharmaceutiques françaises
M Baudrant-BogaB Allenet

Abstract

Patient compliance is a dynamic behaviour, which varies in time and in shape. The impact of poor adherence is medical (loss of immediate benefits and/or long-term) and economic (direct and indirect costs). Adhering and remaining engaged in the daily drug treatment appear to be a challenge for the chronic patient. In this context, we propose as a first step, to describe the evolution of the wording around adherence. This evolution is underlying the paradigm shifts behind this concept and opens new areas for action. Based on this new angle of view that represents the patient's adherence with its drug therapy, we detail the various factors influencing medication adherence categorized into five dimensions: illness, medication, demographic and socio-economic, patient and/or patient support and care system. The impact of these factors is described and explanatory models underlying explicited. Understanding of the issues underlying adherence to drug treatment will help consider further personalized interventions, multi-faceted response to the multiplicity of influencing factors.

References

Dec 1, 1976·Annals of Internal Medicine·E Gordis
Jan 1, 1988·Social Science & Medicine·L D Ried, D B Christensen
Jul 1, 1985·Drugs·C L Peck, N J King
Jan 1, 1984·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·R M KaplanS Reinsch
Jan 1, 1995·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·C J KoningF W Dekker
Oct 2, 1993·BMJ : British Medical Journal·P H BeardonT M MacDonald
Jun 6, 1998·The Milbank Quarterly·D Mechanic
Aug 5, 1997·American Journal of Health Promotion : AJHP·J O Prochaska, W F Velicer
Oct 6, 2001·BMJ : British Medical Journal·S M CampbellM O Roland
Nov 6, 2001·The American Journal of Gastroenterology·S V KaneS B Hanauer
Jan 16, 2002·Medical Care·Michele E WalshLee Sechrest
Feb 2, 2002·Journal of Clinical Nursing·M Toljamo, M Hentinen
Jan 11, 2003·Contraception·M A KuyohM F Gallo
Apr 30, 2003·Diabetes Care·Richard W GrantJames B Meigs
Jan 20, 2004·Patient Education and Counseling·Jane HarringtonStanton P Newman
Jun 24, 2004·Patient Education and Counseling·Marianne Hansson Scherman, Olle Löwhagen
Apr 27, 2005·The American Journal of Medicine·Richard R Rubin
Jun 22, 2005·Revue des maladies respiratoires·A LamourouxD Vervloet
Sep 28, 2005·Diabetes Care·William H PolonskySteven V Edelman
Jul 15, 2006·Chest·Richard S Irwin, Naomi D Richardson
Sep 21, 2006·The Annals of Pharmacotherapy·Hemant M Phatak, Joseph Thomas
Nov 2, 2006·The Annals of Pharmacotherapy·Johnson GeorgeDerek C Stewart
Nov 23, 2006·Patient Education and Counseling·Michael S WolfGregory Makoul
Nov 28, 2006·Patient Education and Counseling·Paul DubersteinRonald M Epstein
Dec 26, 2006·Patient Education and Counseling·Jairo N FuertesLaura S Boylan
Jan 9, 2007·The Journal of Allergy and Clinical Immunology·L Keoki WilliamsManel Pladevall
Feb 20, 2007·La Presse médicale·Nabil Tahri
Mar 24, 2007·British Journal of Clinical Pharmacology·Jeffrey K Aronson
Apr 27, 2007·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Bruce G BenderZung Vu Tran
Jun 15, 2007·Pharmacy World & Science : PWS·Magalie BaudrantJean Calop
Oct 16, 2007·The Journal of Allergy and Clinical Immunology·L Keoki WilliamsManel Pladevall
Dec 7, 2007·The Diabetes Educator·Peggy Soule Odegard, Kam Capoccia
Dec 29, 2007·Social Psychiatry and Psychiatric Epidemiology·Marjan DrukkerPhilippe Delespaul
Jan 19, 2008·Journal of Behavioral Medicine·Karen S Ingersoll, Jessye Cohen
Feb 2, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Joyce A CramerPeter K Wong
Mar 21, 2008·Diabetes/metabolism Research and Reviews·P E Price
Jul 24, 2008·The Annals of Pharmacotherapy·Darcie L KellerHeather A Pace
Jul 31, 2008·Journal of Pediatric Psychology·Stefan SchneiderBruce Simons-Morton
Sep 23, 2008·Patient Education and Counseling·Baiju R Shah, Gillian L Booth

❮ Previous
Next ❯

Citations

Oct 30, 2013·International Journal of Clinical Pharmacy·Audrey LehmannMarie Paule Schneider
Nov 12, 2013·Annales pharmaceutiques françaises·M SallesA Astier
Mar 30, 2013·Annales pharmaceutiques françaises·B AllenetA Golay
Dec 24, 2014·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·L BernardV Sautou
Sep 25, 2016·Thérapie·Julie SiproudhisEmmanuel Oger
Nov 5, 2016·Néphrologie & thérapeutique·Stéphanie BelaicheUNKNOWN réseau Néphronor
Apr 5, 2017·International Journal of Clinical Pharmacy·Stephanie BelaicheMarc Hazzan
Jun 21, 2017·Current Opinion in Psychiatry·Antje D ArltWinfried Rief
Sep 12, 2013·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Chunran Tong, Zhonghe Zhang
Apr 17, 2019·Rheumatology International·Teresa OtónLuis Cea-Calvo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.